Follow
Jesper B Andersen
Jesper B Andersen
Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University
Verified email at bric.ku.dk - Homepage
Title
Cited by
Cited by
Year
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
JM Banales, JJG Marin, A Lamarca, PM Rodrigues, SA Khan, LR Roberts, ...
Nature reviews Gastroenterology & hepatology 17 (9), 557-588, 2020
16152020
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ...
Nature reviews Gastroenterology & hepatology 13 (5), 261-80, 2016
11122016
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
C Coulouarn, VM Factor, JB Andersen, ME Durkin, SS Thorgeirsson
Oncogene 28 (40), 3526-3536, 2009
9112009
Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles
F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ...
Cell reports 18 (11), 2780-2794, 2017
6512017
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors
JB Andersen, B Spee, BR Blechacz, I Avital, M Komuta, A Barbour, ...
Gastroenterology 142 (4), 1021-1031. e15, 2012
5812012
Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients
L Quagliata, MS Matter, S Piscuoglio, L Arabi, C Ruiz, A Procino, M Kovac, ...
Hepatology 59 (3), 911-923, 2014
4442014
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P Wang, Q Dong, C Zhang, PF Kuan, Y Liu, WR Jeck, JB Andersen, ...
Oncogene 32 (25), 3091-3100, 2013
4402013
Common molecular subtypes among Asian hepatocellular carcinoma and cholangiocarcinoma
J Chaisaingmongkol, A Budhu, H Dang, S Rabibhadana, B Pupacdi, ...
Cancer cell 32 (1), 57-70. e3, 2017
3582017
Functional and genetic deconstruction of the cellular origin in liver cancer
JU Marquardt, JB Andersen, SS Thorgeirsson
Nature Reviews Cancer 15 (11), 653-667, 2015
3452015
Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends
MS Matter, T Decaens, JB Andersen, SS Thorgeirsson
Journal of hepatology 60 (4), 855-865, 2014
3202014
Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer
JU Marquardt, L Gomez-Quiroz, LOA Camacho, F Pinna, YH Lee, ...
Journal of hepatology 63 (3), 661-669, 2015
3112015
p53-dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer
DF Tschaharganeh, W Xue, DF Calvisi, M Evert, TV Michurina, LE Dow, ...
Cell 158 (3), 579-592, 2014
2492014
Transcriptomic profiling reveals hepatic stem‐like gene signatures and interplay of miR‐200c and epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma
N Oishi, MR Kumar, S Roessler, J Ji, M Forgues, A Budhu, X Zhao, ...
Hepatology 56 (5), 1792-1803, 2012
2472012
Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway
P Viatour, U Ehmer, LA Saddic, C Dorrell, JB Andersen, C Lin, AF Zmoos, ...
Journal of experimental medicine 208 (10), 1963-1976, 2011
2332011
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types
Á Holczbauer, VM Factor, JB Andersen, JU Marquardt, DE Kleiner, ...
Gastroenterology 145 (1), 221-231, 2013
2072013
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
JM Banales, V Cardinale, G Carpino, M Marzioni, JB Andersen, ...
Nature Reviews Gastroenterology & Hepatology 13 (5), 261-280, 2016
1782016
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
L Izquierdo-Sanchez, A Lamarca, A La Casta, S Buettner, K Utpatel, ...
Journal of hepatology 76 (5), 1109-1121, 2022
1732022
Metabolic rearrangements in primary liver cancers: cause and consequences
L Satriano, M Lewinska, PM Rodrigues, JM Banales, JB Andersen
Nature reviews Gastroenterology & hepatology 16 (12), 748-766, 2019
1712019
Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages
C Raggi, M Correnti, A Sica, JB Andersen, V Cardinale, D Alvaro, ...
Journal of hepatology 66 (1), 102-115, 2017
1502017
A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily
A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ...
Cell systems 7 (4), 422-437. e7, 2018
1482018
The system can't perform the operation now. Try again later.
Articles 1–20